Magnesium Oxide Nanoparticles: A New Frontier in Antiviral Therapy Against Herpes Simplex Virus Type 1
Conclusion: MgONPs can exert their inhibitory effects on HSV-1 in a dose-dependent manner, both directly and through interfering with the replication cycle of the virus.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Advances in Virology |
| Online Access: | http://dx.doi.org/10.1155/av/3088529 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|